Biotech
TUSTIN, CA, and ROCKVILLE, MD: Avid Will Provide Development and Manufacturing Services to Support cGMP Production of an HIV Envelope Protein for ABL's NIH Funded-NIAID Preclinical Development Support Contract HHSN272201100021 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/27/12 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") announces that the Company's operating subsi ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 09/27/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 11th Annua ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/27/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diag ...
SAN DIEGO, CA: Orphan Designation Extended to Both Phase 3 Indications in USA; First Acute Alcoholic Hepatitis Trial Now Ready to Enroll in USA ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/26/12 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX: FLU) is pleased to announce that the Company will be pro ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/26/12 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) today announces that Dr. Rolf Hoffmann, RepliC ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/26/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that at its Board meeting of September 25, 2012 the Board of Directors app ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/26/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT), announced today that its President & Chief Executive Officer, Dr. Wayne Danter, provi ...
PALATINE, IL: PALATINE, IL -- (Marketwire) -- 09/26/12 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address , announced today a letter agreement ...
BURNABY, BRITISH COLUMBIA: BURNABY, BRITISH COLUMBIA -- (Marketwire) -- 09/26/12 -- Lifebank Corp. (TSX VENTURE: LBK) today advises that, in accordance with the Support Agreement between Lifebank and Insception Biosciences In ...
TORONTO, ONTARIO and BURNABY, BRITISH COLUMBIA: TORONTO, ONTARIO and BURNABY, BRITISH COLUMBIA -- (Marketwire) -- 09/26/12 -- Insception Biosciences Inc. and Lifebank Corp. (TSX VENTURE: LBK) announced today that Insception has been successful in ...
PORT HUENEME, CA: PORT HUENEME, CA -- (Marketwire) -- 09/26/12 -- ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) today announced that Frank Oakes, President and Chief Executive Officer o ...
BEDFORD, MA: BEDFORD, MA -- (Marketwire) -- 09/26/12 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced the exercise of the third and final yea ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/25/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") reports that, subject to TSX Venture Exchange appr ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 09/25/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today the completion of an underwritten public offering of 24,638,750 units, including 3,213,750 units sold ...
BOULDER, CO: BOULDER, CO -- (Marketwire) -- 09/25/12 -- InDevR, a privately-held company developing innovative life science instrumentation, announced the availability of created to specific customer requirement ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/25/12 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (TSX: NTB)(NASDAQ: NEPT), a biotechnology company engaged ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwire) -- 09/25/12 -- International Stem Cell Corporation (OTCQB: ISCO) () ("ISCO" or "the Company") a California-based biotechnology company, today announce ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/25/12 -- On June 22, 2012, Warnex Inc. (TSX VENTURE: WNX) ("Warnex" or the "Company") announced that it had received court approval to delay t ...
